Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Braini is a brain health and nutraceutical company dedicated to improving cognitive performance through science-backed nutritional supplements. The company's flagship product, Braini, features a patent-pending formulation of silk protein peptides (Peptylin), plant-based omega fatty acids (NeurXcel), and antioxidant-rich wild blueberry extracts. Braini distinguishes itself in the supplement industry by conducting rigorous, double-blind, placebo-controlled clinical trials to validate its impact on executive function and mental flexibility. The company's research-driven approach aims to provide consumers with safe, non-stimulant alternatives for enhancing mental clarity and long-term neurological health. Headquartered in Asheville, North Carolina, Braini continues to bridge the gap between traditional nutrition and clinical neuroscience.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Braini.